Selected research
Industry Growth & Trends
Global Vendor Neutral Archive (VNA) & PACS Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Vendor Neutral Archive (VNA) & PACS market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Vendor Neutral Archive (VNA) & PACS market include GE Healthcare Technologies Inc., Siemens Healthcare Limited, Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Agfa-Gevaert Group, Sectra AB, Hyland Software, Inc., Intelerad Medical Systems Inc and Merative, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Vendor Neutral Archive (VNA) & PACS market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Vendor Neutral Archive (VNA) & PACS market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vendor Neutral Archive (VNA) & PACS market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vendor Neutral Archive (VNA) & PACS.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Vendor Neutral Archive (VNA) & PACS market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Vendor Neutral Archive (VNA) & PACS Market by Company
GE Healthcare Technologies Inc.
Siemens Healthcare Limited
Canon Medical Systems Corporation
FUJIFILM Holdings Corporation
Agfa-Gevaert Group
Sectra AB
Hyland Software, Inc.
Intelerad Medical Systems Inc
Merative
Novarad Corporation
Esaote SPA
Dedalus s.p.A.
BridgeHead Software Ltd.
PaxeraHealth
Medicasoft
Visus Health IT GmbH
POSTDICOM
Vendor Neutral Archive (VNA) & PACS Segment by Type
CT
MRl
X-rays
Ultrasound
Mammo
PET
Vendor Neutral Archive (VNA) & PACS Segment by Application
Hospital
Surgery Center
Other
Vendor Neutral Archive (VNA) & PACS Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vendor Neutral Archive (VNA) & PACS market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vendor Neutral Archive (VNA) & PACS and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vendor Neutral Archive (VNA) & PACS.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Vendor Neutral Archive (VNA) & PACS companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- CT
- MRl
- X-rays
- Ultrasound
- Mammo
- PET
Applications
- Hospital
- Surgery Center
- Other
Companies covered
- GE Healthcare Technologies Inc.
- Siemens Healthcare Limited
- Canon Medical Systems Corporation
- FUJIFILM Holdings Corporation
- Agfa-Gevaert Group
- Sectra AB
- Hyland Software, Inc.
- Intelerad Medical Systems Inc
- Merative
- Novarad Corporation
- Esaote SPA
- Dedalus s.p.A.
- BridgeHead Software Ltd.
- PaxeraHealth
- Medicasoft
- Visus Health IT GmbH
- POSTDICOM
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Vendor Neutral Archive (VNA) & PACS Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Vendor Neutral Archive (VNA) & PACS Market Size by Region (2021-2032)
- 1.4.1 Global Vendor Neutral Archive (VNA) & PACS Market Size by Region (2021-2026)
- 1.4.2 Global Vendor Neutral Archive (VNA) & PACS Market Size by Region (2027-2032)
- 1.5 Key Regions Vendor Neutral Archive (VNA) & PACS Market Size (2021-2032)
- 1.5.1 North America Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032)
- 1.5.4 South America Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032)
2 Vendor Neutral Archive (VNA) & PACS Market by Type
- 2.1 Type Introduction
- 2.1.1 CT
- 2.1.2 MRl
- 2.1.3 X-rays
- 2.1.4 Ultrasound
- 2.1.5 Mammo
- 2.1.6 PET
- 2.2 Global Vendor Neutral Archive (VNA) & PACS Market Size by Type
- 2.2.1 Global Vendor Neutral Archive (VNA) & PACS Market Size Overview by Type (2021-2032)
- 2.2.2 Global Vendor Neutral Archive (VNA) & PACS Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Vendor Neutral Archive (VNA) & PACS Market Size Forecasted by Type (2027-2032)
- 2.3 Global Vendor Neutral Archive (VNA) & PACS Market Size by Regions
- 2.3.1 North America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026)
3 Vendor Neutral Archive (VNA) & PACS Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Surgery Center
- 3.1.3 Other
- 3.2 Global Vendor Neutral Archive (VNA) & PACS Market Size by Application
- 3.2.1 Global Vendor Neutral Archive (VNA) & PACS Market Size Overview by Application (2021-2032)
- 3.2.2 Global Vendor Neutral Archive (VNA) & PACS Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Vendor Neutral Archive (VNA) & PACS Market Size Forecasted by Application (2027-2032)
- 3.3 Global Vendor Neutral Archive (VNA) & PACS Market Size by Regions
- 3.3.1 North America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Vendor Neutral Archive (VNA) & PACS Industry Trends
- 4.2 Vendor Neutral Archive (VNA) & PACS Industry Drivers
- 4.3 Vendor Neutral Archive (VNA) & PACS Industry Opportunities and Challenges
- 4.4 Vendor Neutral Archive (VNA) & PACS Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Vendor Neutral Archive (VNA) & PACS Revenue (2021-2026)
- 5.2 Global Vendor Neutral Archive (VNA) & PACS Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Vendor Neutral Archive (VNA) & PACS Key Company Headquarters & Area Served
- 5.4 Global Vendor Neutral Archive (VNA) & PACS Company, Product Type & Application
- 5.5 Global Vendor Neutral Archive (VNA) & PACS Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Vendor Neutral Archive (VNA) & PACS Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Vendor Neutral Archive (VNA) & PACS Players Market Share by Revenue in 2025
- 5.6.3 2025 Vendor Neutral Archive (VNA) & PACS Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 GE Healthcare Technologies Inc.
- 6.1.1 GE Healthcare Technologies Inc. Company Information
- 6.1.2 GE Healthcare Technologies Inc. Business Overview
- 6.1.3 GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.1.5 GE Healthcare Technologies Inc. Recent Developments
- 6.2 Siemens Healthcare Limited
- 6.2.1 Siemens Healthcare Limited Company Information
- 6.2.2 Siemens Healthcare Limited Business Overview
- 6.2.3 Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.2.5 Siemens Healthcare Limited Recent Developments
- 6.3 Canon Medical Systems Corporation
- 6.3.1 Canon Medical Systems Corporation Company Information
- 6.3.2 Canon Medical Systems Corporation Business Overview
- 6.3.3 Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.3.5 Canon Medical Systems Corporation Recent Developments
- 6.4 FUJIFILM Holdings Corporation
- 6.4.1 FUJIFILM Holdings Corporation Company Information
- 6.4.2 FUJIFILM Holdings Corporation Business Overview
- 6.4.3 FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.4.5 FUJIFILM Holdings Corporation Recent Developments
- 6.5 Agfa-Gevaert Group
- 6.5.1 Agfa-Gevaert Group Company Information
- 6.5.2 Agfa-Gevaert Group Business Overview
- 6.5.3 Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.5.5 Agfa-Gevaert Group Recent Developments
- 6.6 Sectra AB
- 6.6.1 Sectra AB Company Information
- 6.6.2 Sectra AB Business Overview
- 6.6.3 Sectra AB Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Sectra AB Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.6.5 Sectra AB Recent Developments
- 6.7 Hyland Software, Inc.
- 6.7.1 Hyland Software, Inc. Company Information
- 6.7.2 Hyland Software, Inc. Business Overview
- 6.7.3 Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.7.5 Hyland Software, Inc. Recent Developments
- 6.8 Intelerad Medical Systems Inc
- 6.8.1 Intelerad Medical Systems Inc Company Information
- 6.8.2 Intelerad Medical Systems Inc Business Overview
- 6.8.3 Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.8.5 Intelerad Medical Systems Inc Recent Developments
- 6.9 Merative
- 6.9.1 Merative Company Information
- 6.9.2 Merative Business Overview
- 6.9.3 Merative Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Merative Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.9.5 Merative Recent Developments
- 6.10 Novarad Corporation
- 6.10.1 Novarad Corporation Company Information
- 6.10.2 Novarad Corporation Business Overview
- 6.10.3 Novarad Corporation Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Novarad Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.10.5 Novarad Corporation Recent Developments
- 6.11 Esaote SPA
- 6.11.1 Esaote SPA Company Information
- 6.11.2 Esaote SPA Business Overview
- 6.11.3 Esaote SPA Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Esaote SPA Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.11.5 Esaote SPA Recent Developments
- 6.12 Dedalus s.p.A.
- 6.12.1 Dedalus s.p.A. Company Information
- 6.12.2 Dedalus s.p.A. Business Overview
- 6.12.3 Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.12.5 Dedalus s.p.A. Recent Developments
- 6.13 BridgeHead Software Ltd.
- 6.13.1 BridgeHead Software Ltd. Company Information
- 6.13.2 BridgeHead Software Ltd. Business Overview
- 6.13.3 BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.13.5 BridgeHead Software Ltd. Recent Developments
- 6.14 PaxeraHealth
- 6.14.1 PaxeraHealth Company Information
- 6.14.2 PaxeraHealth Business Overview
- 6.14.3 PaxeraHealth Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 PaxeraHealth Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.14.5 PaxeraHealth Recent Developments
- 6.15 Medicasoft
- 6.15.1 Medicasoft Company Information
- 6.15.2 Medicasoft Business Overview
- 6.15.3 Medicasoft Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Medicasoft Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.15.5 Medicasoft Recent Developments
- 6.16 Visus Health IT GmbH
- 6.16.1 Visus Health IT GmbH Company Information
- 6.16.2 Visus Health IT GmbH Business Overview
- 6.16.3 Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.16.5 Visus Health IT GmbH Recent Developments
- 6.17 POSTDICOM
- 6.17.1 POSTDICOM Company Information
- 6.17.2 POSTDICOM Business Overview
- 6.17.3 POSTDICOM Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 POSTDICOM Vendor Neutral Archive (VNA) & PACS Product Portfolio
- 6.17.5 POSTDICOM Recent Developments
7 North America
- 7.1 North America Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
- 7.3 North America Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
- 8.3 Europe Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
- 10.3 South America Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst